|

DETERMINE: Detemir vs NPH

RECRUITINGPhase 2Sponsored by University of California, Los Angeles
Actively Recruiting
PhasePhase 2
SponsorUniversity of California, Los Angeles
Started2022-02-01
Est. completion2025-06
Eligibility
Age18 Years+
Healthy vol.Accepted
Locations1 site
View on ClinicalTrials.gov →

NCT05124457

Summary

The purpose of the study is to compare rates of neonatal hypoglycemia with maternal NPH vs determir use.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* Inclusion criteria will include pregnant women with pre-existing T2DM and GDM who requiring insulin to manage their blood sugars in pregnancy.

Exclusion Criteria:

1. Multiple Gestation
2. Type 1 Diabetes mellatus
3. Age \< 18
4. Known or suspected hypersensitivity to NPH or insulin detemir
5. Known fetal major malformations
6. Chronic renal or hepatic insufficiency
7. Known to be HIV, Hepatitis B, or Hepatitis C positive
8. Indication for planned premature delivery (placenta accrete, or prior classical cesarean delivery)
9. Insulin dependent before conception

Conditions3

DiabetesDiabetes Mellitus, Type 2Gestational Diabetes

Locations1 site

University of California, Los Angeles
Los Angeles, California, 90069
Christina S Han, MDcshan@mednet.ucla.edu

Browse More Trials

Diabetes trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.